Rare diseases
Investigational molecules
Locations
Back to Czechia1 217 clinical trials in Prague, Czechia across 18 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in CzechiaKlinickeTesty.cz(opens in a new tab)CzechiaCzechiaStudy on ONC201 and Everolimus with Radiotherapy for Newly Diagnosed Diffuse Intrinsic Pontine Glioma and Other Diffuse Midline Gliomas in Children, Adolescents, and Adults
CzechiaStudy on Early Drug Withdrawal in Children with Juvenile Idiopathic Arthritis Using Secukinumab and Drug Combination for Those in Clinical Remission
CzechiaStudy of Lutikizumab, ABBV-382, and Risankizumab for Adults with Moderate to Severe Crohn's Disease
CzechiaEfficacy and Safety of REGN7508, REGN9933, and Rivaroxaban in Adults with Peripheral Artery Disease after Recent Lower‑Extremity Revascularization
CzechiaPrevention of Stroke and Systemic Embolism in Atrial Fibrillation Patients Treated with REGN7508 (cenvacibart) versus Apixaban
CzechiaEfficacy and Safety of Once‑Daily Oral ASC30 in Adults with Obesity or Overweight: A Phase III Randomized Placebo‑Controlled Trial
CzechiaA Phase III Study of ASC30 Sodium for Weight Loss in Adults with Obesity or Overweight and Type 2 Diabetes
CzechiaPhase 3 Study of atebimetinib with gemcitabine and paclitaxel versus gemcitabine and paclitaxel in patients with metastatic pancreatic cancer
CzechiaEffect of zenagamtide on major adverse cardiovascular events in overweight or obese adults with established atherosclerotic cardiovascular disease
CzechiaA Phase 2b Study Evaluating the Efficacy and Safety of ENV-294 in Adults with Moderate-to-Severe Atopic Dermatitis
CzechiaThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on TTR amyloidosis and heart disease treatments, alongside studies investigating hypertriglyceridemia management with novel therapeutics.
Multiple trials evaluating new therapeutic approaches for heart failure prevention and treatment.
Comprehensive studies in prostate cancer and multiple myeloma, with particular focus on metastatic conditions and novel treatment combinations.
Advanced trials comparing innovative therapies against standard treatments in various cancer types.
Extensive vaccine development programs including meningococcal and chickenpox vaccines, alongside studies in immune system disorders.
Focus on immunogenicity and safety in various age groups from infants to adults.
Research into chronic rhinosinusitis and COPD, along with studies on inflammatory bowel conditions.
Evaluating new therapeutic approaches for chronic respiratory and inflammatory conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
